Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Basket Trial Evaluating a Combination of Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumour

NCT03518606 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03518606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03518606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Basket Trial Evaluating a Combination of Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumour
Lead sponsor
UNICANCER
Phase
Phase 1/2
Overall status
Completed
Start date
June 20, 2018
Completion date
December 19, 2024
Enrollment
126 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumours, breast cancer, cervix cancer, head and neck cancer, prostate cancer